AbstractBackground: Blood coagulation occurs by a cascade of zymogen activation resulting from minor proteolysis. The final stage of coagulation involves thrombin generation and limited proteolysis of fibrinogen to give spontaneously polymerizing fibrin. The resulting fibrin network is covalently crosslinked by factor XIIIa to yield a stable blood clot. Fibrinogen is a 340 kDa glycoprotein composed of six polypeptide chains, (αβγ)2, held together by 29 disulfide bonds. The globular C terminus of the γ chain contains a fibrin-polymerization surface, the principal factor XIIIa crosslinking site, the platelet receptor recognition site, and a calcium-binding site. Structural information on this domain should thus prove helpful in understanding ...
We synthesized a variant, recombinant fibrinogen modeled after the heterozygous dysfibrinogen Vlissi...
AbstractRemoval of Bβl-42 from fibrinogen by Crotalus atrox venom results in a molecule lacking fibr...
We synthesized a variant, recombinant fibrinogen modeled after the heterozygous dysfibrinogen Vlissi...
AbstractBackground: Blood coagulation occurs by a cascade of zymogen activation resulting from minor...
© 2017 The Royal Society of Chemistry. The flexible C-terminal parts of fibrinogen's Aα chains named...
Upon activation, fibrinogen forms large fibrin biopolymers that coalesce into clots which assist in ...
Upon activation, fibrinogen forms large fibrin biopolymers that coalesce into clots which assist in ...
Upon activation, fibrinogen forms large fibrin biopolymers that coalesce into clots which assist in ...
Fibrinogen and fibrin play important, overlapping roles in blood clotting, fibrinolysis, cellular an...
Fibrin clot formation is a key event in the development of thrombotic disease and is the final step ...
<p><b>A</b> structure of the fibrinogen molecule (crystal structure 3GHG) with αC domains built in u...
Human fibrinogen 1 is homodimeric with respect to its γ chains (`γA-γA\u27), whereas fibrinogen 2 mo...
Background: Fibrinogen is a large polyfunctional plasma protein consisting of a number of structural...
Studies have linked fibrinogen and fibrin clot structure, strength and stability to cardiovascular d...
Studies have linked fibrinogen and fibrin clot structure, strength and stability to cardiovascular d...
We synthesized a variant, recombinant fibrinogen modeled after the heterozygous dysfibrinogen Vlissi...
AbstractRemoval of Bβl-42 from fibrinogen by Crotalus atrox venom results in a molecule lacking fibr...
We synthesized a variant, recombinant fibrinogen modeled after the heterozygous dysfibrinogen Vlissi...
AbstractBackground: Blood coagulation occurs by a cascade of zymogen activation resulting from minor...
© 2017 The Royal Society of Chemistry. The flexible C-terminal parts of fibrinogen's Aα chains named...
Upon activation, fibrinogen forms large fibrin biopolymers that coalesce into clots which assist in ...
Upon activation, fibrinogen forms large fibrin biopolymers that coalesce into clots which assist in ...
Upon activation, fibrinogen forms large fibrin biopolymers that coalesce into clots which assist in ...
Fibrinogen and fibrin play important, overlapping roles in blood clotting, fibrinolysis, cellular an...
Fibrin clot formation is a key event in the development of thrombotic disease and is the final step ...
<p><b>A</b> structure of the fibrinogen molecule (crystal structure 3GHG) with αC domains built in u...
Human fibrinogen 1 is homodimeric with respect to its γ chains (`γA-γA\u27), whereas fibrinogen 2 mo...
Background: Fibrinogen is a large polyfunctional plasma protein consisting of a number of structural...
Studies have linked fibrinogen and fibrin clot structure, strength and stability to cardiovascular d...
Studies have linked fibrinogen and fibrin clot structure, strength and stability to cardiovascular d...
We synthesized a variant, recombinant fibrinogen modeled after the heterozygous dysfibrinogen Vlissi...
AbstractRemoval of Bβl-42 from fibrinogen by Crotalus atrox venom results in a molecule lacking fibr...
We synthesized a variant, recombinant fibrinogen modeled after the heterozygous dysfibrinogen Vlissi...